View in EDS HTML Full Text PDF Full Text

Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.

Saved in:
Bibliographic Details
Title: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Authors: Sinha, Sanjeev1 (AUTHOR) drsanjeevsinha@gmail.com, Ajayababu, Anuj1 (AUTHOR), Thukral, Himanshu1 (AUTHOR), Gupta, Sushil2 (AUTHOR), Guha, Subhasish Kamal3 (AUTHOR), Basu, Ayan4 (AUTHOR), Gupta, Gaurav1 (AUTHOR), Thakur, Prashant2 (AUTHOR), Lingaiah, Raghavendra5 (AUTHOR), Das, Bimal Kumar6 (AUTHOR), Singh, Urvashi B.6 (AUTHOR), Singh, Ravinder6 (AUTHOR), Narang, Rajiv7 (AUTHOR), Bhowmik, Dipankar8 (AUTHOR), Wig, Naveet1 (AUTHOR), Modak, Dolan Champa3 (AUTHOR), Bandyopadhyay, Bhaswati9 (AUTHOR), Chakrabarty, Banya10 (AUTHOR), Kapoor, Aditya11 (AUTHOR), Tewari, Satyendra11 (AUTHOR)
Source: Infectious Diseases & Therapy. Dec2022, Vol. 11 Issue 6, p2205-2217. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938229
DOI:10.1007/s40121-022-00703-y